Your browser doesn't support javascript.
loading
Sex-related differences in the trends and outcomes of trans-septal transcatheter mitral valve replacement: Insights from the National Readmissions Database.
Elbadawi, Ayman; Tan, Bryan E-Xin; Sammour, Yasser; Saad, Marwan; Omer, Mohamed; Baron, Suzanne J; Sharaf, Barry; Abbott, J Dawn; Gordon, Paul C.
Afiliação
  • Elbadawi A; Division of Cardiology, Baylor College of Medicine, Houston, Texas, USA.
  • Tan BE; Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA.
  • Sammour Y; Department of Internal Medicine, University of Missouri Kansas City, Kansas City, Missouri, USA.
  • Saad M; Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Omer M; Division of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Baron SJ; Division of Cardiovascular Medicine, Department of Medicine, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
  • Sharaf B; Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Abbott JD; Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Gordon PC; Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Catheter Cardiovasc Interv ; 99(5): 1636-1644, 2022 04.
Article em En | MEDLINE | ID: mdl-35132765
ABSTRACT

BACKGROUND:

There is a paucity of data regarding the sex-related differences in the trends and outcomes of trans-septal transcatheter mitral valve replacement (TS-TMVR).

METHODS:

The Nationwide Readmissions Database (2015-2018) was queried for admissions for TS-TMVR. Propensity matched analysis was conducted to compare outcomes with hospitalizations for TS-TMVR among women versus men. The main study outcome was in-hospital mortality.

RESULTS:

Our final analysis included 2063 hospitalizations for TS-TMVR; of whom, 58.1% were women. The proportion of women among those undergoing TS-TMVR increased from 50% in 2015 to 60.2% in 2018 (Ptrend = 0.04). Compared with men, women undergoing TS-TMVR were slightly younger, and had a distinct profile of comorbidities. After matching, there was no significant difference in in-hospital mortality among women versus men undergoing TS-TMVR (7.8% vs. 6.1%, OR = 1.30; 95% CI 0.79-2.13). Subgroup analyzes showed an interaction toward higher mortality with women versus men among patients with CKD (Pinteraction = 0.07). There were no significant differences between women and men in in-hospital complications or length of stay after TS-TMVR. Compared with men, women undergoing TS-TMVR were more likely to be discharged to a nursing facility (17.7% vs. 11.5%, p = 0.01) and had higher rates of 30-day readmissions (22.4% vs. 13.6%, p = 0.01).

CONCLUSION:

This nationwide analysis showed an increase in the proportion of women among patients undergoing TS-TMVR during the study years. There were no differences in in-hospital mortality, in-hospital complications, or length of stay between both sexes following TS-TMVR. Women were more likely to be discharged to nursing facilities and had higher rates of readmission at 30 days even after propensity matching.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Implante de Prótese de Valva Cardíaca / Insuficiência da Valva Mitral Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Implante de Prótese de Valva Cardíaca / Insuficiência da Valva Mitral Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article